FIELD: medicine, resuscitation.
SUBSTANCE: one should detect cerebral perfusion pressure (CPP), intracranial pressure (ICP), values for blood saturation with oxygen in radial artery and jugular vein bulb (SaO2, SjO2), additionally one should study lactate level in jugular vein bulb and radial artery, calculate venous-arterial difference according to lactate (▵lactate), cardiac ejection (CE) due to thermodilution and hemoglobin level. Values for cerebral oxygen transport function should be calculated by the following formulas: mĎO2 = 0.15 x CE x CaO2 x 10; mVO2 = 015 x CE x (CaO2 - CjO2) x 10; CaO2 = 1.3 x Hb x SaO2; CjO2 = 1.3 x Hb x SjO2. In case of noninvasive detection - due to pulsoxymetry one should measure peripheral saturation (SpO2), due to parainfrared spectroscopy - cerebral oxygenation (rSO2) and cardiac ejection due to tetrapolar rheovasography (CEr), detect and calculate the values of cerebral oxygen transport system according to the following formulas: mĎO2 = 0.15 x CEr x CaO2 x 10; mVO2 = 0.15 x CEr x (CaO2 - CjO2) x 10; CaO2 = 1.3 x Hb x SpO2; CjO2 = 1.3 x Hb x rSO2. At the value of mĎO2 86-186 ml/min and more, MVO2 33 - 73 ml/min, ▵lactate below 0.4 mM/l one should evaluate cerebral oxygen transport system to be normal and the absence of cerebral metabolic disorders. At mĎO2 values below 86 ml/min, mVO2 being 33-73 ml/minO2, ▵lactate below 0.4 mM/l one should state upon compensated cerebral oxygen transport system and the absence of metabolic disorders. At mĎO2 being below 86 ml/min, mVO2 below 33 mM/l, ▵lactate below 0.4 mM/l one should conclude upon cerebral oxygen transport system to be subcompensated at decreased metabolism. At the values of mĎO2 being 86-186 ml/min and more, MVO2 below 33 ml/min, ▵lactate below 0.4 mM/l one should establish subcompensated cerebral oxygen transport system at decreased metabolism. At values of lactate being above 0.4 mM/l and any values of mĎO2 and mVO2 one should point out the state of decompensation in cerebral oxygen transport system and its metabolism. The innovation enables to diagnose disorders and decrease the risk for the development of secondary complications.
EFFECT: higher efficiency and accuracy of evaluation.
1 cl, 3 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF SELECTION OF PRESSURE REGULATING PREPARATION FOR ADEQUATE CEREBRAL PERFUSION IN ACUTE CEREBRAL INJURY | 2011 |
|
RU2469645C1 |
METHOD FOR DETERMINING ORGANISM TISSUE OXYGEN UTILIZATION DEGREE | 2002 |
|
RU2241378C2 |
PREDICTION METHOD FOR ISCHEMIC CEREBRAL AFFECTION DEVELOPMENT FOLLOWING ACUTE SUBARACHNOID HAEMORRHAGE CAUSED BY ARTERIAL ANEURYSM RUPTURE ASSOCIATED WITH INTRACRANIAL HYPERTENSION IN CEREBRAL VASOSPASM | 2007 |
|
RU2353297C2 |
METHOD FOR CEREBRAL CIRCULATION AND MISPERFUSION ASSESSMENT | 2007 |
|
RU2401059C2 |
METHOD FOR VITAL PROTECTION IN CARDIAC SURGERY PATIENTS UNDERWENT ON-PUMP SURGERY | 2009 |
|
RU2398601C1 |
METHOD FOR DETERMINATION OF VENOUS BLOOD OXYGEN LEVEL | 2005 |
|
RU2298185C1 |
METHOD OF DIAGNOSING DEGREE OF SECONDARY CEREBRAL ISCHEMIA EXPRESSION AFTER SURGICAL ABLATION OF MALIGNANT NEOPLASM OF BRAIN | 2011 |
|
RU2463950C1 |
METHOD FOR TREATMENT OF BRAIN EDEMA | 2007 |
|
RU2332988C1 |
METHOD FOR SELECTING WAY FOR TRANSFERRING CRANIOCEREBRAL INJURY PATIENTS TO SELF- STANDING BREATHING | 2002 |
|
RU2223121C2 |
NONINVASIVE METHOD FOR DETERMINING INTRACRANIAL PRESSURE IN CHILDREN | 2001 |
|
RU2204946C1 |
Authors
Dates
2005-11-20—Published
2004-01-08—Filed